Jianchang Lin

20PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsMolecular targetsChemotherapyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With <i>EGFR</i> Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial.

Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho

|Dec 12, 2024
A multiple imputation approach in enhancing causal inference for overall survival in randomized controlled trials with crossover.

Ruochen Zhao, Junjing Lin, Jing Xu

|Apr 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling.

Wei Wei, Ondrej Blaha, Denise Esserman

|Oct 20, 2023
BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.

Dehua Bi, Meizi Liu, Jianchang Lin

Pageof 4